NSE · TRIGYN
Trigyn Technologies Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹47 Cr with net profit ₹11 Cr — a 22.92% net margin, versus 2.12% the period before.
Shareholding
As of 2026-06-30
- Promoter44.51%
- Public55.36%
- FII0.12%
- DII0.01%
31,751 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.73× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — LT-ASM · ASM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Computers - Software - Medium / Small · ranked #130 of 284 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| PB FinTech Limited | ₹74,549 Cr | 285.17 | 10.2 | 9.16% | 9.86% |
| Inventurus Knowledge Solutions Ltd. | ₹31,229 Cr | 147.78 | 11.09 | 25.77% | 22.59% |
| Tata Technologies Limited | ₹30,145 Cr | 46.31 | 9.33 | 15.63% | 9.4% |
| Affle 3i Limited | ₹23,292 Cr | 194.39 | 6.37 | 12.45% | 16.79% |
| Tata Elxsi Limited | ₹22,885 Cr | 32.46 | 7.52 | 22.89% | 16.84% |
| Sagility Limited | ₹21,005 Cr | 80.13 | 2.17 | 9.57% | 12.86% |
| Firstsource Solutions Ltd. | ₹20,757 Cr | 98.85 | 4.67 | 17.13% | 7.01% |
| eClerx Services Ltd. | ₹18,357 Cr | 95.35 | 7.01 | 27.57% | 17.15% |
| KPIT Technologies Ltd. | ₹17,507 Cr | 106.61 | 4.91 | 18% | 9.87% |
| IDream Film Infrastructure Company Ltd. | ₹17,315 Cr | — | 65.82 | 39.1% | 0% |
| Trigyn Technologies Ltd.(this company) | ₹165 Cr | 78.68 | 0.21 | 0.26% | 0.2% |
AI analysis
AI-generated · google/gemini-2.5-flashTrigyn Technologies Ltd. is listed with a market capitalization of Rs 166 Cr. The company reported revenue of Rs 915.79 Cr with a profit margin of 20.3%. Its earnings per share (EPS) stands at Rs 0.68, and it has a book value of Rs 258.79. The debt-to-equity ratio is 0.01.
Positives
- +The company's debt-to-equity ratio is low at 0.01.
- +The profit margin for the latest annual period stood at 20.3%.
Negatives
- −Revenue growth for the latest financial year was negative at -29.8%.
- −Return on capital employed (ROCE) is low at 2.22%.
- −The company is under LT-ASM surveillance, indicating regulatory concerns.
Financial Performance
Trigyn Technologies Ltd. reported annual revenue of Rs 915.79 Cr in Mar 2025. This represents a revenue growth of -29.8%. The company’s net profit for the same period was Rs 11.7694 Cr, with a profit margin of 20.3%.
Profitability & Returns
The company's earnings per share (EPS) for the latest reported period is Rs 0.68. Return on equity (ROE) is 26.4%, while return on capital employed (ROCE) is 2.22%. The annual net profit for Mar 2025 was Rs 11.7694 Cr.
Balance Sheet
Trigyn Technologies Ltd. has a book value per share of Rs 258.79. The company maintains a low debt-to-equity ratio of 0.01, indicating minimal reliance on borrowed capital. There is no dividend yield reported for the company.
Ownership & Pledges
As of June 30, 2026, promoters held 44.5072% of the company's shares. Public shareholding was 55.3584%, FIIs held 0.1247%, and DIIs held 0.0097%. Institutions collectively held 0.1344%. There are no promoter shares pledged reported as of the latest disclosure.
Regulatory & Surveillance
Trigyn Technologies Ltd. is currently under LT-ASM (Long Term Additional Surveillance Measure) Stage 1. This classification indicates heightened monitoring by regulatory authorities, affecting market transactions for the stock.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.